Vanaja Kethireddy, MD
Obstetrics & Gynecology · San Antonio, TXNPI 1518083013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.
Across 51 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$225
- AbbVie$136
- Pfizer$90
- Roche Diagnostics Corporation$73
- Avion Pharmaceuticals$61
- Astellas Pharma US Inc$56
- plus $311 from 14 others
What the payments were for
- Food & beverage$951100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 8 | $225 |
| AbbVie | 7 | $136 |
| Pfizer | 5 | $90 |
| Roche Diagnostics Corporation | 4 | $73 |
| Avion Pharmaceuticals | 4 | $61 |
| Astellas Pharma US Inc | 3 | $56 |
| Millicent US Inc | 2 | $35 |
| Organon | 2 | $33 |
| Merck | 2 | $32 |
| Mayne Pharma Commercial LLC | 3 | $31 |
| Shield Therapeutics Inc | 2 | $31 |
| Acessa Health Inc. | 1 | $26 |
| Exeltis, USA Inc. | 1 | $24 |
| Radius Health, Inc. | 1 | $18 |
| Biogen | 1 | $17 |
| Coopersurgical, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $12 |
| Meditrina | 1 | $4 |
How this compares
$951 in reported general payments places this provider in the 50th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $859 |
| ValacyclovirValacyclovir Hcl | 13 | $377 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Antonio
- Henry Garza IiiSan Antonio$258K
- Valentin AlmendarezSan Antonio$215K
- Camilo GonimaSan Antonio$203K
- Paulina RamirezSan Antonio$51K
- Paula BilicaSan Antonio$41K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.